Status:
NOT_YET_RECRUITING
Comparing Hydrocortisone and Prednisolone for Community Acquired Pneumonia (CAP)
Lead Sponsor:
Copenhagen Respiratory Research
Conditions:
Community Acquired Pneumonia (CAP)
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The goal of this cluster randomized controlled trial is to determine the optimal treatment for community aquired pneumonia (CAP). The study compares the effects and side effects of hydrocortisone and ...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Diagnosis of severe CAP for who the physician in charge decides for corticosteroid therapy for severe CAP.
Exclusion
- Admitted \>24 h
- Pregnant or breastfeeding women
- Active tuberculosis or fungal infection
- Pneumonia caused by influenza
- Intolerance to either study drug
Key Trial Info
Start Date :
August 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2026
Estimated Enrollment :
1600 Patients enrolled
Trial Details
Trial ID
NCT06892197
Start Date
August 1 2025
End Date
November 1 2026
Last Update
March 30 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.